Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MST1: A future novel target for cardiac diseases. | Int J Biol Macromol | 2023 | 37011743 | PubTator, text mining | PubMed |
| Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes. | Front Endocrinol (Lausanne) | 2023 | 37008937 | PubTator, text mining | PubMed |
| Mammalian Ste20-like kinase 1 inhibition as a cellular mediator of anoikis in mouse bone marrow mesenchymal stem cells. | World J Stem Cells | 2023 | 37007455 | PubTator, text mining | PubMed |
| Advances in the potential roles of Cullin-RING ligases in regulating autoimmune diseases. | Front Immunol | 2023 | 37006236 | PubTator, text mining | PubMed |
| Protective effects of melatonin on myocardial microvascular endothelial cell injury under hypertensive state by regulating Mst1. | BMC Cardiovasc Disord | 2023 | 37005605 | PubTator, text mining | PubMed |
| Cytoplasmic YAP1-mediated ESCRT-III assembly promotes autophagic cell death and is ubiquitinated by NEDD4L in breast cancer. | Cancer Commun (Lond) | 2023 | 37005481 | PubTator, text mining | PubMed |
| Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics. | Medicine (Baltimore) | 2023 | 37000102 | PubTator, text mining | PubMed |
| Possible Future Avenues for Rheumatoid Arthritis Therapeutics: Hippo Pathway. | J Inflamm Res | 2023 | 36998323 | PubTator, text mining | PubMed |
| Morpho-Functional Effect of a New Collagen-Based Medical Device on Human Gingival Fibroblasts: An In Vitro Study. | Biomedicines | 2023 | 36979765 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing in Family Trios Reveals De Novo Mutations Associated with Type 1 Diabetes Mellitus. | Biology (Basel) | 2023 | 36979105 | PubTator, text mining | PubMed |
| Structural basis of bacteriophage T5 infection trigger and E. coli cell wall perforation. | Sci Adv | 2023 | 36961893 | PubTator, text mining | PubMed |
| Human umbilical cord mesenchymal stem cells conditioned medium exerts anti-tumor effects on KGN cells in a cell density-dependent manner through activation of the Hippo pathway. | Stem Cell Res Ther | 2023 | 36941685 | PubTator, text mining | PubMed |
| Investigation of Hippo pathway-related prognostic lncRNAs and molecular subtypes in liver hepatocellular carcinoma. | Sci Rep | 2023 | 36941336 | PubTator, text mining | PubMed |
| Knocking down GALNT6 promotes pyroptosis of pancreatic ductal adenocarcinoma cells through NF-κB/NLRP3/GSDMD and GSDME signaling pathway. | Front Oncol | 2023 | 36925932 | PubTator, text mining | PubMed |
| Mob4 is required for neurodevelopment in zebrafish. | MicroPubl Biol | 2023 | 36915897 | PubTator, text mining | PubMed |
| Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer. | Oncol Lett | 2023 | 36909377 | PubTator, text mining | PubMed |
| Human umbilical cord mesenchymal stem cells derived extracellular vesicles alleviate salpingitis by promoting M1-to-M2 transformation. | Front Physiol | 2023 | 36875046 | PubTator, text mining | PubMed |
| Mechanotransduction pathways in articular chondrocytes and the emerging role of estrogen receptor-α. | Bone Res | 2023 | 36869045 | PubTator, text mining | PubMed |
| Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses. | EBioMedicine | 2023 | 36857861 | PubTator, text mining | PubMed |
| Long non-coding RNA DLX6-AS1 is the key mediator of glomerular podocyte injury and albuminuria in diabetic nephropathy by targeting the miR-346/GSK-3β signaling pathway. | Cell Death Dis | 2023 | 36854759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=27